Prognostic significance of the pretreatment pan-immune-inflammation value in colorectal cancer patients: an updated meta-analysis.

ABSTRACT:

Background

The prognostic importance of the pretreatment pan-immune-inflammation value (PIV) in colorectal cancer has been extensively documented, yet its role remains unclear. This study aims to conduct an updated meta-analysis to elucidate the relationship between the pretreatment PIV and long-term survival outcomes among patients diagnosed with colorectal cancer.

Methods

A systematic literature review was performed in PubMed, Embase, Web of Science and CNKI to identify eligible studies from inception to January 18, 2025. The primary endpoints evaluated were survival outcomes. Hazard ratios (HRs) along with their corresponding 95% confidence intervals (CIs) for survival outcomes were extracted. A random-effects model was utilized to synthesize the findings. All statistical

SUBMITTER: Li J 

PROVIDER: S-EPMC12328146 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature